The effects of awareness, treatment and control of hypertension on future stroke incidence in a community-based population study in Finland

Journal of Hypertension

Volumn 27, Issue 7, 2009, Pages 1459-1465

  Barengo, Noël C ^a,b   Hu, Gang ^a,c   Kastarinen, Mika ^d   Antikainen, Riitta ^e,f   Tuomilehto, Jaakko ^a,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e Oulu City Hospital   (Finland)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

Control; Hemorrhagic; Hypertension; Ischemic; Stroke; Subarachnoid; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; FINLAND; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 67649806884     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832b7d8b     Document Type: Article

References (34)

1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part II - variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation2001; 104:2855-2864.
2. Mohr JP, Albers GW, Amarenco P, Babikian VL, Biller J, Brey RL, et al.American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Etiology of stroke. Stroke 1997; 28: 1501-1506.
3. Manolio TA, Kronmal RA, Burke GL, O'Leary DH, Price TR. Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke 1996; 27:1479-1486.
4. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006; 24:423-430.
5. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al.Blood pressure, stroke and coronary heart disease. Part 2: short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-839.
6. Dahlö B, Lindholm LH, Hansson L, Scherste'n B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP-Hypertension). Lancet 1991; 338:1281-1285.
7. Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens 1995; 9:175-180.
8. Antikainen R, Jousilahti P, Tuomilehto J. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens 1998; 16:577-583.
9. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
10. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265:3255-3264.
11. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhä ger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757-764.
12. Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45:907-913.
13. Hansson L, Zanchetti A, Carruthers SG, Dahlö f B, Elmfeldt D, Julius S, et al.Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal treatment (HOT) randomized trial. HOT Study Group. Lancet 1998; 351:1755-1762.
14. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood pressure lowering drugs: results of prospectively designed overview on randomised trials. Lancet2000; 356:1955-1964.
15. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35:776-785.
16. Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK. Stroke and coronary heart disease in treated hypertension: a prospective cohort study over three decades. J Intern Med 2005; 257:b496-b502.
17. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317:b167-b171.
18. Lindblad U, Ra°stam L, Ranstam J. Stroke morbidity in patients treated for hypertension: the Skaraborg Hypertension Project. J Intern Med 1993; 233:155-163.
19. Li C, Engström G, Hedblad B, Berglund G, Janzon L. Blood pressure control and risk of stroke: a population-based prospective cohort study. Stroke 2005; 36:725-730.
20. Casiglia E, Mazza A, Tikhonoff V, Scarpa R, Guglielmi F, Pessina AC. Arterial hypertension and mortality in the elderly. Am J Hypertens 2002; 15:958-966.
21. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol2000; 29:49-56.
22. Kastarinen MJ, Antikainen RL, Laatikainen TK, Salomaa VV, Tuomilehto JO, NissinenAM, Vartiainen EA. Trends in hypertension care in eastern andsouthwestern Finland during 1982-2002. J Hypertens 2006; 24:829-836.
23. Tuomilehto J, Vartiainen E, Sarti C, Nissinen A, Kastarinen M. Trends in hypertension, cardiovascular risk and stroke mortality in Finland. In: Bulpitt C, editor. Epidemiology of hypertension, hypertension handbook. Amsterdam: Elsevier Science B.V; 2000. pp. 633-644.
24. Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo N, Tuomilehto J. Leisure-time, occupational, and commuting physical activity and the risk of stroke. Stroke 2005; 36:1994-1999.
25. Leppä lä JM, Virtamo J, Heinonen OP. Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol 1999; 15:155-160.
26. Klungel OH, Stricker BH, Paes AH, Seidell JC, Bakker A, Voko Z, et al.Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke 1999; 30:1312-1318.
27. Klungel OH, Kaplan RC, Heckbert SR, Smith NL, Lemaitre RN, Longstreth WT Jr, et al. Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 2000; 31:420- 424.
28. Yamada S, Koizumi A, Iso H, Wada Y, Watanabe Y, Date C, et al., Japan Collaborative Cohort Study Group. Risk factors for fatal subarachnoid hemorrhage: the Japan Collaborative Cohort Study. Stroke 2003; 34:2781-2787.
29. Teunissen LL, Rinkel GJ, Algra A, van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke 1996; 27:544-549.
30. Knekt P, Reunanen A, Aho K, Heliö vaara M, Rissanen A, Aromaa A, Impivaara O. Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol 1991; 44:933-939.
31. Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Antikainen R, Tuomilehto J. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 2005; 36:2538-2543.
32. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21:707-716.
33. Woodward M, Barzi F, Martiniuk A, Fang X, Gu DF, Imai Y, et al. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol2006; 35:1412-1416.
34. Woodward M, Huxley H, Lam TH, Barzi F, Lawes CM, Ueshima H. A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Eur J Cardiovasc Prev Rehabil 2005; 12:484-491.